Table 3. Summary of results of medical vs surgical treatment.
| Medical (N=8) | Surgical (N=8) | P-value | |
|---|---|---|---|
| Average age (years) | 61.5 | 54.3 | 0.35 |
| Gender (M) | 25% M | 62.5% M | NS |
| Average LOS (days) | 9.38 | 8.25 | 0.79 |
| Focal deficits on presentation | 0 | 4 | NS |
|
Comorbidities (average/patient) | |||
| All | 3.63 | 1.38 | 0.026 |
| Cardiovasculara | 4.38 | 1.63 | 0.0076 |
| Risk of death/negative outcome (%) | 25% | 25% | — |
| Microorganisms | MRSA (3) | MRSA (2) | |
| MSSA | Klebsiella (2) | ||
| Staph+Strep | MSSA | ||
Abbreviations: LOS, length of stay; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus; NS, not significant.
a
Cardiovascular including: congestive heart failure, atrial fibrillation, hypertension, myocardial infarction, thrombosis, etc.